View in EDS HTML Full Text PDF Full Text

Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results.

Saved in:
Bibliographic Details
Title: Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results.
Authors: Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Meredith DM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Driver J; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Du Z; Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China., Hoffman S; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Li Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA., Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Beroukhim R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA., Rinne M; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., McFaline-Figueroa R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., McCluskey C; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Gaffey S; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Stefanik J; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Doherty L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Taubert C; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Cifrino M; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., LaFrankie D; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Graillon T; Faculté de Médecine, Aix Marseille Université, Marseille, France., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Ligon KL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Al-Mefty O; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Huang RY; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Muzikansky A; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA., Santagata S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Dunn IF; Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Source: Neuro-oncology [Neuro Oncol] 2022 Jan 05; Vol. 24 (1), pp. 101-113.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34015129
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bi+WL%22">Bi WL</searchLink>; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Nayak+L%22">Nayak L</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Meredith+DM%22">Meredith DM</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Driver+J%22">Driver J</searchLink>; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Du+Z%22">Du Z</searchLink>; Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Hoffman+S%22">Hoffman S</searchLink>; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Lee+EQ%22">Lee EQ</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Beroukhim+R%22">Beroukhim R</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Rinne+M%22">Rinne M</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22McFaline-Figueroa+R%22">McFaline-Figueroa R</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Chukwueke+U%22">Chukwueke U</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22McCluskey+C%22">McCluskey C</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Gaffey+S%22">Gaffey S</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Cherniack+AD%22">Cherniack AD</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Stefanik+J%22">Stefanik J</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Doherty+L%22">Doherty L</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Taubert+C%22">Taubert C</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Cifrino+M%22">Cifrino M</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22LaFrankie+D%22">LaFrankie D</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Graillon+T%22">Graillon T</searchLink>; Faculté de Médecine, Aix Marseille Université, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Wen+PY%22">Wen PY</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Ligon+KL%22">Ligon KL</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Al-Mefty+O%22">Al-Mefty O</searchLink>; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Huang+RY%22">Huang RY</searchLink>; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Muzikansky+A%22">Muzikansky A</searchLink>; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Chiocca+EA%22">Chiocca EA</searchLink>; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Santagata+S%22">Santagata S</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Dunn+IF%22">Dunn IF</searchLink>; Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.<br /><searchLink fieldCode="AU" term="%22Reardon+DA%22">Reardon DA</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2022 Jan 05; Vol. 24 (1), pp. 101-113.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34015129
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/neuonc/noab118
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101
    Titles:
      – TitleFull: Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bi WL
      – PersonEntity:
          Name:
            NameFull: Nayak L
      – PersonEntity:
          Name:
            NameFull: Meredith DM
      – PersonEntity:
          Name:
            NameFull: Driver J
      – PersonEntity:
          Name:
            NameFull: Du Z
      – PersonEntity:
          Name:
            NameFull: Hoffman S
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Lee EQ
      – PersonEntity:
          Name:
            NameFull: Beroukhim R
      – PersonEntity:
          Name:
            NameFull: Rinne M
      – PersonEntity:
          Name:
            NameFull: McFaline-Figueroa R
      – PersonEntity:
          Name:
            NameFull: Chukwueke U
      – PersonEntity:
          Name:
            NameFull: McCluskey C
      – PersonEntity:
          Name:
            NameFull: Gaffey S
      – PersonEntity:
          Name:
            NameFull: Cherniack AD
      – PersonEntity:
          Name:
            NameFull: Stefanik J
      – PersonEntity:
          Name:
            NameFull: Doherty L
      – PersonEntity:
          Name:
            NameFull: Taubert C
      – PersonEntity:
          Name:
            NameFull: Cifrino M
      – PersonEntity:
          Name:
            NameFull: LaFrankie D
      – PersonEntity:
          Name:
            NameFull: Graillon T
      – PersonEntity:
          Name:
            NameFull: Wen PY
      – PersonEntity:
          Name:
            NameFull: Ligon KL
      – PersonEntity:
          Name:
            NameFull: Al-Mefty O
      – PersonEntity:
          Name:
            NameFull: Huang RY
      – PersonEntity:
          Name:
            NameFull: Muzikansky A
      – PersonEntity:
          Name:
            NameFull: Chiocca EA
      – PersonEntity:
          Name:
            NameFull: Santagata S
      – PersonEntity:
          Name:
            NameFull: Dunn IF
      – PersonEntity:
          Name:
            NameFull: Reardon DA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 01
              Text: 2022 Jan 05
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1523-5866
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Neuro-oncology
              Type: main
ResultId 1